Overview
iPACK Block for Total Knee Arthroplasty
Status:
Active, not recruiting
Active, not recruiting
Trial end date:
2024-12-30
2024-12-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
This randomized, double-blinded, placebo-controlled trial seeks to evaluate the efficacy of the rehabilitation process of the Interspace between the Popliteal Artery and Capsule of the Posterior Knee (iPACK) block in total knee arthroplasty.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Poznan University of Medical SciencesTreatments:
Ropivacaine
Criteria
Inclusion Criteria:- Patients > 18 years old undergoing unilateral total knee arthroplasty
Exclusion Criteria:
- refusal to participate
- < 18 yo
- Chronic opioid use
- localized infection